| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Futura Medical narrows annual losses on lower R&D spend
StockMarketWire.com
|
Pharmaceutical company Futura Medical reported narrower losses as research and development spend fell sharply.
For the year ended 31 December 2020, pre-tax losses narrowed to £2.9 million from £11.1 million.
Research and development costs fell to £1.9 million from £10.0 million.
'The company is well positioned to deliver further positive news through 2021 especially around commercialisation of MED3000 and our objective to deliver a long term and sustainable revenue for shareholders,' the company said.
At 10:10am: (LON:FUM) Futura Medical PLC share price was 0p at 14.75p
Story provided by StockMarketWire.com
|
|
|
|
|
|
